Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would rather smoke this Tweed bud....
http://liftcannabis.ca/uploads/92cab10186353b2f30ca0d1f26631e3a.jpg">http://liftcannabis.ca/uploads/92cab10186353b2f30ca0d1f26631e3a.jpg" />
0.540 +0.040 (+8.00%) -- BLO moving on up and holding strong
When this is all over I will be printing up 100 complimentary "BOB was Wrong" t-shirts,.. bet I have a line up of people that want to Sport that T
First time in a very long time that I see Argyle sold out,. hope they have more in the vault.
Not sure why TD Securities has been bringing it down, selling like a champion today. Maybe trying to go through some stop loss's to grab more cheapies.
With patients like those and you don't need many patients... quite the $tash
GOD is GUD. :)
They need to tie Bill up and have a good ol fashion stoning. Glad I never got sucked into that fiasco.
It is shocking that there are still "buyers" of FITX,.. 27.14 Million new BAG HOLDERS so far today.... unbelievable.
"TWEED is nothing more than a hobby compared to some of the commercial grow operations in Colorado.... "
Throwing a statement out there like that, you have my curiosity. How about providing a link to ANY Colorado grow op that is bigger than Tweed?
BLO SP is holding strong, smart money is holding as this has a long way to go up. Prototype to be released soon, then this goes viral. Cheers to longs.
KHTRF is the OTC Ticker for Americans
or
GUD on the TSX for Canadians
LONG on this one.
GUD is flying along nicely,.. Paladin II is in GUD hands, Goodman building another BEAST!
Bedrocan Board with Activity is not this board,.. the other board has over 600 hundred posts, cheers.
http://investorshub.advfn.com/Bedrocan-Cannabis-Corp-TSXV-BED-28648/
I wonder how much of their oil payouts will go towards MJ.
Last year every Alaskan received $1,884 Each times 559,000 Alaskans, $1,053,156,000
Will be quite the tax grab for Uncle Sam.
Seems more like a stoner trial than anything else. Makes me even more confident with the MMPR system and the LP's.
13 strains down to 9 strains in 24 hours, back to 10 this afternoon. Product is moving!
Available
ARGYLE (Nordle)
ARGYLE
(Nordle)
$6
BALMORAL (UK Cheese)
BALMORAL
(UK Cheese)
$9
BIRDS EYE (Jack Herer)
BIRDS EYE
(Jack Herer)
$9
BOGART (OG Kush)
BOGART
(OG Kush)
$9
BUDDY (L.A. Confidential)
BUDDY
(L.A. Confidential)
$5
CLARENCE (Chocolope)
CLARENCE
(Chocolope)
$9
DONEGAL (Chem Dawg)
DONEGAL
(Chem Dawg)
$9
HERRINGBONE (AK-47)
HERRINGBONE
(AK-47)
$9
LEONIDAS (Super Silver Haze)
LEONIDAS
(Super Silver Haze)
$6
MILTON (Cocoa Kush)
MILTON
(Cocoa Kush)
$9
Institutional Ownership has now Increased to 24.84%,.. a year ago it was sitting at just 8%.
Holders Shares
Increased Positions 51 4,931,467
Decreased Positions 40 1,228,961
Held Positions 32 13,828,480
Total Institutional Shares 123 19,988,908
Read more: http://www.nasdaq.com/symbol/onvo/institutional-holdings#ixzz3SgznuxTo
Hebert said he tried to call LPs several times for information, but that he got put on hold and didn't have his calls returned at all...
That is quite the load of horse pucky,.. Hebert should have to provide phone bills to back that BS up!
and ACB coming right back down as I predicted on Friday. No big surprise.
Bed is a true winner with 13 years of MMJ experience!
Tweed in the Lead
Available
ARGYLE (Nordle)
ARGYLE
(Nordle)
$6
BAKERSTREET (Hindu Kush)
BAKERSTREET
(Hindu Kush)
$6
BALMORAL (UK Cheese)
BALMORAL
(UK Cheese)
$9
BIRDS EYE (Jack Herer)
BIRDS EYE
(Jack Herer)
$9
BOGART (OG Kush)
BOGART
(OG Kush)
$9
BUDDY (L.A. Confidential)
BUDDY
(L.A. Confidential)
$5
CLARENCE (Chocolope)
CLARENCE
(Chocolope)
$9
DONEGAL (Chem Dawg)
DONEGAL
(Chem Dawg)
$9
HIGH LANDS (East Coast Sour Diesel)
HIGH LANDS
(East Coast Sour Diesel)
$12
HOUNDSTOOTH (Super Lemon Haze)
HOUNDSTOOTH
(Super Lemon Haze)
$9
LEONIDAS (Super Silver Haze)
LEONIDAS
(Super Silver Haze)
$6
MILTON (Cocoa Kush)
MILTON
(Cocoa Kush)
$9
SIXTY THREE (Chocolate Chunk)
SIXTY THREE
(Chocolate Chunk)
$9
That is between Feb 9th - Feb 20th (aprox 16 million shares)
http://www.stockwatch.com/Quote/Detail.aspx?action=go&snapshot=SX&symbol=BLO®ion=C
Nice to see a few healthy days of consolidation.
Approximately 16 million shares have traded on the CSE in the range of 37-77 cents. Looks at though a nice 50 cent base is forming. I am expecting neutral to small upward movements until the prototype is released, then the SP goes viral!
I am on your page
Tweed #1
Bedrocan #2
Organigram #3
Mettrum #4
Aphria #5
The rest don't float my boat for various reasons.
Sometimes after a Halt there is a big pop,.. two companies halted, BED and ACB both related to MMPR license. ACB had quite the pop this morning, up to around 36%, but drifting down now, as I write this up 26%. They have too many O/S's, I expect ACB SP to come right back down. First Alberta MMPR, so maybe some of the oil guys throwing money at this one.
BED are experts, they in my mind are a better choice, with time this will keep ticking up. Brand new industry in Canada, early birds will cash in big time on the long haul.
Cheers
Delusional, what kind of dreamer thinks ILLEGAL CC's WILL be the only source for edibles as HC won't allow LP's,.. but a judge will grant approval through black market CC's and not legit LP's??? Holy delusional batman, what kind of country does he think Canada is?
I will say it right now, I am expecting to see shake in a new form,.. pre-mixed blends of multiple strains. Salads per say, seems like a smart solution to put a new spin on trim.
Not really that careful, he said the SP went up 8% on news,... meanwhile it really went up 19%.
You are beyond delusional.
Bedrocan receives Health Canada MMPR Production License
Bedrocan receives Health Canada MMPR Production License
Second Licensed Site Allows for Transition to Domestic Production
Import Permit Issued for Transfer of Genetic Clones from the Netherlands
TORONTO, Feb. 19, 2015 /CNW/ - Bedrocan Cannabis Corp. (TSXV: BED) ("Bedrocan" or the "Company") announced today that its wholly-owned subsidiary, Bedrocan Canada Inc., has received a second license from Health Canada to allow for the production of medicinal cannabis under the Marihuana for Medicinal Purposes Regulations ("MMPR"). Under the terms of this license, which became effective on February 17, 2015 for a period of one year, Bedrocan can immediately begin domestic production in the first six grow rooms, out of a total of 34, at the Company's new 52,000 square foot production facility in the Greater Toronto Area. When fully licensed by Health Canada, the facility is capable of producing approximately 4,000 kg of medicinal cannabis per year.
Bedrocan now has two licensed facilities in operation in the Greater Toronto Area. As previously announced on December 3, 2014, Bedrocan also has an existing Health Canada license, which was renewed for an additional one year term expiring on December 2, 2015, to import up to 240 kg from the Dutch government's Office of Medicinal Cannabis. The Company will now begin the transition to full domestic production, constituting Phase II of the Company's growth strategy.
Furthermore, Health Canada has also issued Bedrocan an import permit to allow for immediate transfer of live genetic clones from Bedrocan BV in the Netherlands to the Company's domestic production facility. Bedrocan's import permit from Health Canada follows the issuance of an additional import permit from the Canadian Food Inspection Agency, allowing for the first ever legal import of live cannabis plants into Canada.
"We are delighted to have reached this critical milestone in our growth strategy, allowing us to significantly scale up the volume of product we can offer to Canadian patients," said Marc Wayne, President and CEO. "We remain on schedule to deliver our first production harvest and sale in Q2'2015. In addition, our import strategy will remain in place through transition to full domestic production to ensure a continued, consistent and uninterrupted supply of medicinal cannabis to our patients."
Bedrocan is the only company in the world capable of offering patients standardized full-bud dried cannabis, containing consistent levels of cannabinoids (the active ingredients) from batch to batch. Product standardization is the only way to provide physicians and patients with consistency and replicability of therapeutic effect, and thereby enhanced ability to track efficacy, safety and side effects over time. Production at the new domestic facility will be grown from clones that are genetically identical to those developed by Bedrocan BV.
About Bedrocan
Bedrocan and Bedrocan BV are focused on medicinal cannabis research and product innovation, and have been producing and supplying government-regulated medicinal cannabis for 13 years. Bedrocan's strains of pharmaceutical-grade cannabis have been used by more than 20,000 patients in seven countries, including Canada. The Company is committed to clinical research with ISO 9001-rated production processes and product development, on an international scale. Bedrocan is one of only two companies currently supplying pharmaceutical-grade medicinal cannabis in Canada. Bedrocan Cannabis Corp. trades on the TSX Venture Exchange under the symbol "BED". www.bedrocan.ca
Forward-Looking Statements
Certain information in this release are forward-looking statements with respect to the development plans and growth targets of the Company. Forward-looking statements consist of statements that are not purely historical, including statements regarding beliefs, plans, expectations or intensions for the future, and include, but not limited to, statements with respect to: (a) the commencement of domestic production of medicinal cannabis by the Company, and capacity for such production; (b) the Company's plan to scale up the volume of its product available to Canadian patients; and (c) the success of the Company's import and domestic production strategy. The basis for the assumptions underlying such statements include that: (i) Bedrocan's existing licenses will remain in full force and effect, and be renewed upon terms acceptable to Bedrocan in the future; (ii) actual results of the Company's planned domestic production and development activities will continue to be positive and proceed as planned; (iii) all requisite regulatory and governmental approvals will be received on a timely basis on terms acceptable to the Company, and (iv) economic, political and industry market conditions will be favourable. However, such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including, but not limited to: (1) the risk that domestic production may not be achieved as planned; (2) changes in project parameters as plans evolve; (3) dependence on regulatory approvals and changes in legislation, environmental compliance, community support and the political and economic climate; (4) availability of future financing; and (5) the timely completion of the Company's production facility and other factors beyond the control of the Company. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company assumes no obligation to update such information, except as may be required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Bedrocan Cannabis Corp.
For further information:
Cam Battley, Bedrocan Cannabis Corp.
cbattley@bedrocan.ca
+1.905.864.5525
www.bedrocan.ca
Investor relations:
Jennifer Wood,
TMX Equicom
jwood@tmxequicom.com
+1.416.815.0700, ext. 226
http://www.newswire.ca/en/story/1490401/bedrocan-receives-health-canada-mmpr-production-license
CND Close - 0.530 +0.030 (+6.00%) Feb 19 - Close
Another stable day of consolidation, getting ready for another leg up.
74 Strain Reviews - Looking really GOOD!
http://liftcannabis.ca/producers/tweed/reviews
Not today, but a month ago. He is a good guy to talk to and for anyone that has any questions at all, don't be shy and just call.
I really like how he has made time for investors to call like this, surely not a regular event with most companies. Kudo's to Bruce and Tweed!
079 is stocking up
CND Exchange moving up 0.530 +0.030 (+6.00%)
This company is a VERY unique breed, unlike the rest of the LP's. I don't see a merger, but maybe a partnership?
A post from a different board below:
Probably is HC but I heard another juicy tidbit the other day.
Don't have any details BUT I did hear about a project or partnership that will triple their client base.
I expect things went well, spoke to management about two weeks ago and they were all ready and very confident, they were just waiting on Health Canada.
I honestly expect good news. Hope so, own a wack of BED too.
Investors have been waiting a long time for this news, it is not uncommon in Canada for a stock to be Halted before big news at the request of the company. I expect it to be news about the HC inspection, sure hope all went well with the inspection, holding a wack of 74's. Cheers.
I expect news about Health Canada Inspection on the facility.
Halted at 12:21 today --- At the Request of the Company Pending News